Cited by 438Computational Drug Discovery MethodsSynthesis and Characterization of Heterocyclic Compoundsvaccines and immunoinformatics approaches

Recognizing Pitfalls in Virtual Screening: A Critical Review

Scior, Thomas, Bender, Andreas, Tresadern, Gary, Medina-Franco, José L., Martínez-Mayorga, Karina, Langer, Thierry, Cuanalo-Contreras, Karina, Agrafiotis, Dimitris K.·2012·Journal of Chemical Information and Modeling

Abstract

The aim of virtual screening (VS) is to identify bioactive compounds through computational means, by employing knowledge about the protein target (structure-based VS) or known bioactive ligands (ligand-based VS). In VS, a large number of molecules are ranked according to their likelihood to be bioactive compounds, with the aim to enrich the top fraction of the resulting list (which can be tested in bioassays afterward). At its core, VS attempts to improve the odds of identifying bioactive molecules by maximizing the true positive rate, that is, by ranking the truly active molecules as high as possible (and, correspondingly, the truly inactive ones as low as possible). In choosing the right approach, the researcher is faced with many questions: where does the optimal balance between efficiency and accuracy lie when evaluating a particular algorithm; do some methods perform better than others and in what particular situations; and what do retrospective results tell us about the prospective utility of a particular method? Given the multitude of settings, parameters, and data sets the practitioner can choose from, there are many pitfalls that lurk along the way which might render VS less efficient or downright useless. This review attempts to catalogue published and unpublished problems, shortcomings, failures, and technical traps of VS methods with the aim to avoid pitfalls by making the user aware of them in the first place.

Integrity signals

Registry

Crossref · 10.1021/ci200528d

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K.
Affiliations
  • Pharmacy Department, Facultad de Ciencias Químicas, Universidad Autónoma de Puebla, Puebla, Pue, México
  • University of Cambridge (GB)
  • Research Informatics & Integrative Genomics, Janssen Research & Development, Calle Jarama 75, Poligono Industrial, Toledo 45007, Spain
  • Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States
  • Prestwick Chemical, Blvd Gonthier dʼAndernach, F-67400 Illkirch, France
  • Janssen Research & Development (United States) (US)
Corresponding author
Scior, Thomas
Venue
Journal of Chemical Information and Modeling
Published
2012-04-06
Volume
52
Issue
4
Pages
867-881
ISSN
  • 1549-9596 (ISSN-L)
  • 1549-960X
OpenAlex
W2008732224
Cited by
438
References
124
Citations by year
2026: 18 · 2025: 22 · 2024: 29 · 2023: 29 · 2022: 30 · 2021: 34 · 2020: 29 · 2019: 38 · 2018: 33 · 2017: 23 · 2016: 24 · 2015: 34 · 2014: 42 · 2013: 42 · 2012: 11
FWCI
4.63
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chemical Information and Modeling (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
virtual screening, structure-based virtual screening, ligand-based virtual screening, bioactive compound identification, diagnostic sensitivity, method comparison
MeSH terms
Algorithms, Binding Sites, Humans, Ligands, Protein Binding, Proteins, Structure-Activity Relationship, User-Computer Interface, Likelihood Functions, Small Molecule Libraries, High-Throughput Screening Assays, Molecular Docking Simulation, Databases, Chemical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review